IDEX Biometrics ASA IDXAF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -8.86% | 161.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.86% | 161.74% | |||
| Cost of Revenue | 74.28% | -83.47% | |||
| Gross Profit | -69.54% | 126.63% | |||
| SG&A Expenses | -35.72% | 114.54% | |||
| Depreciation & Amortization | -1.66% | -47.68% | |||
| Other Operating Expenses | 14.82% | 4.01% | |||
| Total Operating Expenses | -10.98% | 30.92% | |||
| Operating Income | 11.13% | -26.39% | |||
| Income Before Tax | 77.03% | -41.10% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 77.03% | -41.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 77.03% | -41.10% | |||
| EBIT | 11.13% | -26.39% | |||
| EBITDA | 11.27% | -55.76% | |||
| EPS Basic | 79.51% | -4.06% | |||
| Normalized Basic EPS | 50.52% | -993.02% | |||
| EPS Diluted | 79.51% | 0.81% | |||
| Normalized Diluted EPS | 50.52% | -993.02% | |||
| Average Basic Shares Outstanding | 12.35% | 35.77% | |||
| Average Diluted Shares Outstanding | 12.35% | 35.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||